YouTube Facebook LinkedIn Google+ Twitter Xinginstagram rss  

Browse Top Headlines

Search Text
Start Date
End Date

Sure Genomics Wants to Sell Private Genetic Profiles for $2500

TODAY | The Verge | Sure Genomics, a startup based in Utah, launched a whole genome testing service today, but its plan to report a host of important health results is really testing the FDA.

The Search for Schizophrenia Genes

| Slate | Larger and larger genetic studies are finding smaller and smaller effect sizes. What does this mean for drug development, clinical practice, and our view of mental illness?

New Type of CRISPR Screen Probes the Regulatory Genome

| Bio-IT World | Scientists at MIT and Brigham and Women's Hospital have invented a "multiplexed editing regulatory assay" (MERA) to test large swathes of the genome in parallel for regulatory elements that can turn gene activity on and off over the course of a cell's development.

Debugging Science Experiments at Elemental Machines

| Xconomy | A Cambridge startup is trying to remove extraneous variables from experiments with a "smart lab" that can better control for simple factors like temperature and humidity.

Mobile DNA Sequencing in the Ebola Epidemic

| Bio-IT World | The results of a months-long effort to sequence virus samples in the middle of the largest Ebola outbreak in history, using the handheld MinION DNA sequencer and a miniature mobile lab, have been published in Nature.

Funding Biology in the Cloud

| Forbes | Is the future of biology in the cloud? Palo Alto-based venture fund, Andreesen Horowitz has created a new $200 million fund to invest in the idea.

Venter Expands Attempt to Fight Disease, Increase Lifespan

| San Diego Union-Tribune | J. Craig Venter's company Human Longevity, Inc. has purchased LifebankUSA, a biobank that preserves stem cells from cord blood and placental tissue, growing an enterprise that will soon begin sequencing infants' genomes as a service.

UK Scientists Gain Licence to Edit Genes in Human Embryos

| Nature News | A team at Francis Crick Institute has been permitted to use CRISPR-Cas9 technology in embryos for early-development research, but the work is still many steps away from genome-edited human beings.

January News and Product Briefs

| Bio-IT World | The latest products and announcements from around the industry, including a high-throughput protein conformation analyzer, and updates to the cloud-based genome analysis services of both DNAnexus and Seven Bridges.

'Remarkable Turning Point' as Medical Journals Require Clinical Trial Data Sharing

| STAT | Harlan Krumholz, of the Yale Open Data Access project, speaks about a new proposal by the International Committee of Medical Journal Editors.

Scientists Move Closer to Understanding Schizophrenia’s Cause

| New York Times | A massive genomic study provides researchers with a strong case for a biological mechanism involved in the disorder, and helps explain why it often begins at a relatively young age.

Ferring Pharmaceuticals to Fund Research Center for Microbiome-Based Therapies

| Bio-IT World News Brief | Swiss drugs company Ferring Pharmaceuticals will fully fund the creation of a joint research center with the Karolinska Institutet of Sweden, to conduct human microbiome studies with an eye on new therapies.

Illumina Buys Conexio for HLA Typing Business

| Bio-IT World News Brief | Illumina has purchased Conexio Genomics, an Australian company that was one of the first to develop products for using next-generation sequencing in matching tissue donors and recipients through HLA genotyping.

The Forest in Your Mouth

| Phenomena | A study using many parallel probes has revealed the spatial organization of different bacterial species in dental plaque. The strategy could be used to explore microbial ecology in all sorts of environments.

How the World's Governments Have Regulated Human Genome Editing

| Bio-IT World | Members of McGill University’s Centre of Genomics and Policy have published a global survey of restrictions on modifying the human genome, concluding that many regulations are vague and that bans or limitations often relax over time.

Data Scientists = Research Parasites?

| Forbes | David Shaywitz weighs in on yesterday's editorial from NEJM calling data scientists "research parasites." He was glad, he says, for a major objection to finally be laid out. Now we can move past it.

Why Data Scientist Is This Year's Hottest Job

| Computerworld | It's notable enough that close to half of the 25 "best jobs in America" named by recruiting site Glassdoor this week are tech-related, but even more striking is the fact that "data scientist" tops the list.

Pharma Industry Calls on Governments to Fund New Antibiotics

| Phenomena | At the World Economic Forum in Davos, a group of almost 100 pharma companies and trade associations have released a bare bones outline of a plan to spur research into new antibiotics and encourage their responsible use.

Can Big Genomic Data Reveal the Fundamental Units of the Brain?

| Bio-IT World | An ambitious new study from the Allen Institute for Brain Science illustrates how new methods for isolating and studying single cells, combined with massive RNA sequencing data, are changing the way neuroscientists think about the variety and organization of cells in the brain.

The Muscular Dystrophy Patient and Olympic Medalist with the Same Genetic Disorder

| ProPublica | David Epstein tells the story of how a woman whose muscles disappeared discovered, through years of dogged research, that she shared a disease with a muscle-bound Olympic athlete.

For reprints and/or copyright permission, please contact Terry Manning, 781.972.1349.